These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 30725482)

  • 1. Microglia in Alzheimer's disease: A target for immunotherapy.
    Wang S; Colonna M
    J Leukoc Biol; 2019 Jul; 106(1):219-227. PubMed ID: 30725482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting microglia for the treatment of Alzheimer's Disease.
    Wes PD; Sayed FA; Bard F; Gan L
    Glia; 2016 Oct; 64(10):1710-32. PubMed ID: 27100611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM2 in CNS homeostasis and neurodegenerative disease.
    Painter MM; Atagi Y; Liu CC; Rademakers R; Xu H; Fryer JD; Bu G
    Mol Neurodegener; 2015 Sep; 10():43. PubMed ID: 26337043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREM2, Microglia, and Neurodegenerative Diseases.
    Yeh FL; Hansen DV; Sheng M
    Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease.
    Lewcock JW; Schlepckow K; Di Paolo G; Tahirovic S; Monroe KM; Haass C
    Neuron; 2020 Dec; 108(5):801-821. PubMed ID: 33096024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response.
    Jiang T; Zhang YD; Gao Q; Ou Z; Gong PY; Shi JQ; Wu L; Zhou JS
    Inflammation; 2018 Jun; 41(3):811-823. PubMed ID: 29362997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
    Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
    Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is the regulation of immune system in Alzheimer's disease effective? ].
    Shirakawa H
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):319. PubMed ID: 27181729
    [No Abstract]   [Full Text] [Related]  

  • 9. TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation.
    Magno L; Bunney TD; Mead E; Svensson F; Bictash MN
    Mol Neurodegener; 2021 Apr; 16(1):22. PubMed ID: 33823896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
    Lue LF; Schmitz C; Walker DG
    Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease.
    Hashemiaghdam A; Mroczek M
    J Neuroimmunol; 2020 Apr; 341():577185. PubMed ID: 32045774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vps35-dependent recycling of Trem2 regulates microglial function.
    Yin J; Liu X; He Q; Zhou L; Yuan Z; Zhao S
    Traffic; 2016 Dec; 17(12):1286-1296. PubMed ID: 27717139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.
    Nizami S; Hall-Roberts H; Warrier S; Cowley SA; Di Daniel E
    Br J Pharmacol; 2019 Sep; 176(18):3515-3532. PubMed ID: 30740661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Roles of microglia and immune receptors in Alzheimer's disease].
    He X; Sun BG
    Yao Xue Xue Bao; 2014 Jun; 49(6):774-80. PubMed ID: 25212020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis.
    Neumann H; Takahashi K
    J Neuroimmunol; 2007 Mar; 184(1-2):92-9. PubMed ID: 17239445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREM2 sustains microglial expansion during aging and response to demyelination.
    Poliani PL; Wang Y; Fontana E; Robinette ML; Yamanishi Y; Gilfillan S; Colonna M
    J Clin Invest; 2015 May; 125(5):2161-70. PubMed ID: 25893602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurodegenerative disease and TREM2].
    Takahashi K
    Rinsho Shinkeigaku; 2014; 54(12):1122-4. PubMed ID: 25519966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains.
    Zhu C; Herrmann US; Li B; Abakumova I; Moos R; Schwarz P; Rushing EJ; Colonna M; Aguzzi A
    Neurobiol Aging; 2015 May; 36(5):1994-2003. PubMed ID: 25816748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.